I'm guessing I'm not the only member of this community who found a marketing message for a new Alzheimer's drug in their inbox this morning? I was surprised to learn that Allergan is a "partner" in the AgingCare initiative. I object to this form of targeted marketing, particularly to individuals who are most susceptible and in need of solutions. Until we know how safe or effective this new drug is, I would caution anyone against adding yet another drug to their loved one's armamentarium of medications. However, if any existing members have had experience with this NAMENDA XR, I'm sure we'd all love to hear about it. It's not clear from the offensive email ad or the website what this drug does or how it works.
I did not receive the email myself though.
Angel
What does bother me is the lack of privacy and misuse and abuse of our e-mail addresses.
This is the address of the offensive e-mail. You could write to the AC staff and advise them that you don't want this junk mail.
AgingCare Exclusive Offers" (less than sign) reply-fe9717747660017875-121040_HTML-218720801-1065940-0@email.agingcare.com (greater than sign) --- the filters are blocking the use of those signs.
Note that it isn't from Namenda; it's from Aging Care.